Chemistry: molecular biology and microbiology – Differentiated tissue or organ other than blood – per se – or...
Reexamination Certificate
2011-05-17
2011-05-17
Anderson, James D (Department: 1614)
Chemistry: molecular biology and microbiology
Differentiated tissue or organ other than blood, per se, or...
C128S898000
Reexamination Certificate
active
07943292
ABSTRACT:
Artificial plasma-like solutions and methods for their use are provided. The subject solutions include: electrolytes and an oncotic agent. The subject solutions find use in a variety of applications, particularly in those applications where at least a portion of a host's blood volume is replaced with a blood substitute.
REFERENCES:
patent: 3937821 (1976-02-01), Irikura et al.
patent: 4001401 (1977-01-01), Bonsen et al.
patent: 4061736 (1977-12-01), Morris et al.
patent: 4216205 (1980-08-01), Radiwitz
patent: 4606912 (1986-08-01), Rudy et al.
patent: 4649050 (1987-03-01), Veech
patent: 4663166 (1987-05-01), Veech
patent: 4812310 (1989-03-01), Sato et al.
patent: 4879283 (1989-11-01), Belzer et al.
patent: 4908350 (1990-03-01), Kramer et al.
patent: 4923442 (1990-05-01), Segall et al.
patent: 4927806 (1990-05-01), Kramer et al.
patent: 5082831 (1992-01-01), Leaf et al.
patent: 5084377 (1992-01-01), Rowan et al.
patent: 5120719 (1992-06-01), Iwamoto et al.
patent: 5130230 (1992-07-01), Segall et al.
patent: RE34077 (1992-09-01), Segall et al.
patent: 5171526 (1992-12-01), Wong et al.
patent: 5200398 (1993-04-01), Strasberg et al.
patent: 5210083 (1993-05-01), Pfirrman
patent: 5274001 (1993-12-01), Borody
patent: 5306711 (1994-04-01), Andrews
patent: 5374624 (1994-12-01), Segal
patent: 5407428 (1995-04-01), Segall et al.
patent: 5407793 (1995-04-01), Del Nido et al.
patent: 5571801 (1996-11-01), Segall et al.
patent: 5696152 (1997-12-01), Southard
patent: 6080538 (2000-06-01), Segall et al.
patent: 437274 (1991-07-01), None
patent: 0701455 (2001-03-01), None
patent: WO89/10746 (1989-11-01), None
patent: WO92/18136 (1992-10-01), None
patent: WO94/28950 (1994-12-01), None
patent: WO 9402895 (1994-12-01), None
patent: WO96/19918 (1996-07-01), None
(1987). “6% Dextran 70 in 5% Dextrose injection or 0.9% Sodium Chloride injection” 06-3874-R8-Rev. Abbot Laboratories, North Chicago, IL 60064, US.
(1992). “Media Formulas” ATCC Catalogue of Bacteria & Bacteriophages, p. 486.
Altura et al., “CA2+ coupling in vascular smooth muscle: Mg2+ and buffer effects on contractility and membrane Ca2+ movements”, Canadian Journal of Physiology and Pharm., 1982, 60(4) (459-482), abst.
Bailes et al. (1990), “The use of Ultra-profound Hypothermia in a totally exsanguinated and Blood-Substituted canine model, I,” Cyrobiology, V. 27: 622-623.
Belzer et al. (1985). “Combination perfusion-cold storage for optimum cadaver kidney function and utilization” Transplantation, V. 39(2): 118-121.
Bishop et al. (1978). “Evaluation of hypertonic citrate flushing solution for kidney preservation using the isolated perfused rat kidney” Transplantation, V. 25(5): 235-239.
Collins (1977). Hypothermic kidney storage Transplantation Proceedings, V. 9(3): 1529-1534.
Fischer et al. (1985). “Flush solution 2, a new concept for one to three day hypothermic renal storage preservation” Transplantation, V. 39(2): 122-126.
Hull et al. “Effect of HEPES buffer on corneal storage in MK medium”, Acta Ophthalmologica, 1984, 62(6) 900-10, abst.
Kallerhoff et al. (1985). “Effects of preservation conditions and temperature on tissue acidification in canine kidneys” Transplantation, V. 39(5): 485-489.
Leavitt et al. (1990) “Survival from prolonged cardiac arrest in totally exsanguinated hypothermic dogs” FASB J., V. 4(4): A 983.
Lehninger (1975). Biochemistry, 2ndEdition, p. 829ff.
Lepe-Zuniga et al., “Toxicity of Light-Exposed HEPES Media”, J Immunol Methods 103, 145 (1987).
Rosenberg (1969). “Perspectives on the Problem of Blood Substitutes”. Proc. 12thCongr. Int. Soc. Blood Transf. No. 3 Pt .II pp. 737-745.
Ross et al., “72 hr Canine Kidney Preservation Without Continuous Perfusion” Transplantation (1976), B.21 (6): 498-501.
Segall et al., (1991). “Animal Models in Ice Cold Bloodless Medicine” FASB J., V.5 (4): A396.
Smith (1956), “Studies on Golden Hamsters During Cooling to and Rewarming from Body Temperatures Below 0°C.,” Proc. Royal Soc. vol. 145: 391-442.
Spahn (1994). “Cardiovascular and Coronary Physiology of Acute Isovolemic Hemodilution: A review of Nonoxygen-Carrying and Oxygen-Carrying Solutions”. Anesth. Analg. V. 78:1000-1021.
Sternberg et al., (1990). “Interventive Gerontology, Cloning and Cyronics” Biomedical Advances in Aging. Plenum Press. Ch. 19 pp. 207-219.
Wagner et al. (1993). “Pharacologic and Clinical Considerations in Selecting Crystalloid, Collodial and Oxygen-Carrying Resuscitation Fluids, Part 1” Clin. Pharm. V. 12: 335-347.
Waitz et al. (1991). “Hamsters Live After Hours of Bloodless Hyperbaric 02” FASB J., V. 5(5); 4375.
Wiedesberg et al. “Anemic Necrosis of the Liver After Umbilical Vein Catherization”, Helvetica Paediatrica Acta, (1979), 34(a) 53-62, abstract.
Segall Judith M.
Segall Paul E.
Sternberg Hal
Waitz Harold D.
Anderson James D
BioTime, Inc.
Bozicevic Field & Francis LLP
Field Bret E.
Foulds Glenn J.
LandOfFree
Physiologically acceptable aqueous solutions and methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Physiologically acceptable aqueous solutions and methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Physiologically acceptable aqueous solutions and methods for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2667405